Klouda P T, Jeannet M
Lancet. 1976 Apr 24;1(7965):876-8. doi: 10.1016/s0140-6736(76)92094-8.
Serial serum samples from 35 renal allograft recipients were screened for cold and warm cytotoxic antibodies using a two-stage microlymphocytotoxicity test with three incubation temperatures. Both cold and warm antibodies were reactive at 22 degrees C. The critical temperatures which distinguished the two classes of antibodies were 15 degrees C and 37 degrees C. Cold antibodies were detected in sera from 15 patients, 10 patients had warm antibodies, and the remaining 10 had a mixture of cold and warm antibodies. All the patients were cytotoxin-positive after transplantation, although not all had preformed lymphocytotoxins. At one year 14 of the patients with cold autoantibodies had functioning grafts, but only 3 of the 10 patients with warm antibodies had kidneys functioning. This difference was statistically highly significant. There was no difference in graft survival among patients with warm antibodies and those with a mixture of cold and warm antibodies.
采用两阶段微淋巴细胞毒性试验,在三个孵育温度下,对35例肾移植受者的系列血清样本进行了冷、热细胞毒性抗体筛查。冷抗体和热抗体在22摄氏度时均有反应。区分这两类抗体的临界温度分别为15摄氏度和37摄氏度。在15例患者的血清中检测到冷抗体,10例患者有热抗体,其余10例同时有冷抗体和热抗体。所有患者移植后细胞毒素均呈阳性,尽管并非所有患者都有预先形成的淋巴细胞毒素。一年后,14例有冷自身抗体的患者移植肾仍有功能,但10例有热抗体的患者中只有3例肾脏仍有功能。这种差异在统计学上具有高度显著性。有热抗体的患者与有冷抗体和热抗体混合的患者之间,移植肾存活率没有差异。